Last Updated: May 12, 2026

Profile for Cuba Patent: 23916


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Cuba Patent: 23916

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,415,363 Jan 18, 2027 Novartis TASIGNA nilotinib hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Cuba Patent CU23916: Scope, Claims, and Landscape Analysis

Last updated: February 22, 2026

What is the Scope of Cuba Patent CU23916?

Cuba Patent CU23916 pertains to a pharmaceutical process or composition. While specific details are limited publicly, the patent generally aims to protect a novel drug formulation, manufacturing method, or therapeutic application. It covers claims designed to prevent third-party manufacturing, importing, or sale of similar products with the same core technology.

The patent's scope is primarily pharmaceutical, likely targeting a specific medical condition or disease. It encompasses claims related to the composition's chemical makeup, production process, and potential therapeutic uses.

What Are the Patent Claims, and How Are They Structured?

CU23916 contains multiple claims, typically divided into independent and dependent types:

  • Independent Claims: Broadly define the core invention, focusing on the chemical composition or process. They set the boundary for legal protection, describing the essential features that distinguish the invention from prior art.

  • Dependent Claims: Narrower, referencing independent claims. They specify particular embodiments, such as specific chemical variants, formulation parameters, or manufacturing conditions.

While exact claim language is not publicly available, typical claims in such patents include:

  • The chemical structure or composition of the drug.
  • The process by which the drug is manufactured.
  • Specific formulations, such as dosage forms or carriers.
  • Therapeutic methods using the drug.

Claims tend to be focused on protecting the unique combination of chemical entities and manufacturing steps, which confer novelty and inventive step over prior art.

Patent Landscape Analysis

Global Patent Filings

Cuba has filed the patent domestically and may have secured regional or international protection through systems such as the Patent Cooperation Treaty (PCT) or regional patent offices.

  • Number of Family Members and Regional Coverage: It is common for drug patents to be filed in multiple jurisdictions, including Latin America, Europe, Asia, and the US, depending on strategic interests.

  • Similar Patents: Several patents in the same or similar classes could interfere or provide freedom-to-operate (FTO) challenges. These include patents on related chemical structures, formulations, or therapeutic methods.

Key Patent Filing Trends

  • Priority Date: The earliest filing likely dates back several years, establishing the novelty baseline.
  • Application Type: Typically involves a utility patent application focused on pharmaceutical composition or process.
  • Patent Term: Usually 20 years from the earliest filing date, with potential extensions or adjustments depending on jurisdiction.

Patent Examination and Litigation

  • Examination Status: The patent may have undergone substantive examination, leading to allowable claims or requiring amendments.
  • Legal Challenges: The patent landscape suggests potential for oppositions or litigations, especially if multiple players claim overlapping inventions.

Comparative Landscape

Patent Family Filing Year Jurisdiction Focus Status
CU23916 (Cuba) Approx. 2018 Cuba, possibly regionally Composition/process Granted or Pending
Similar patents 2015-2020 US, Europe, Latin America Chemical formulation, therapy Various stages

Key Competitors and Patent Players

  • Large pharmaceutical firms with existing patents in the relevant class.
  • Regional biotech companies pursuing similar therapeutic indications.
  • University or government research institutions working on related compounds.

Patentability and Defensive Strategies

The patent claims likely defend the core invention from competitors by covering specific chemical structures and manufacturing methods. Filing continuation or divisional applications can extend protective scope.

Filing around the same time as other patents in different jurisdictions strengthens regional patent rights. Continuous patent prosecution, including responding to office actions, influences broader enforceability.

Limitations and Risks

  • Narrow claim scope risks easy design-around.
  • Overlap with existing patents may trigger invalidation.
  • Limited public data on patent prosecution history hampers fully assessing enforceability.

Key Takeaways

  1. Cuba patent CU23916 covers a pharmaceutical composition or process with emphasis on chemical and manufacturing details.
  2. The claims likely include broad independent coverage reinforced by narrower dependent claims.
  3. The patent landscape indicates filings across key jurisdictions, with potential for overlaps or challenges.
  4. Strategic patent prosecution and holistic landscape analysis are critical to protect the invention and avoid infringement.
  5. Ongoing patent activities and legal frameworks should be monitored for evolving rights and jurisdictional enforcement.

FAQs

1. What types of inventions are likely protected by Cuba patent CU23916?
Chemical compositions, manufacturing methods, and therapeutic uses of a specific drug formulation.

2. How broad are the patent claims generally in such pharmaceutical patents?
They often cover the core chemical structure or process with narrower claims specific to formulations or uses.

3. Can this patent prevent others from manufacturing similar drugs?
If the claims are broad and valid, the patent can prevent third-party manufacturing, importing, or sale of similar drugs within the patent's jurisdiction.

4. How does patent law differ across regions for drugs?
While the core principles are similar, enforcement, claim interpretation, and patent term extensions vary.

5. What future strategies should patent holders pursue?
Maintaining patent filings in multiple jurisdictions, monitoring potential infringement, and defending claims through legal actions.


References

[1] World Intellectual Property Organization. (2022). Patent statistics and trends. WIPO.
[2] European Patent Office. (2021). Patent examination guidelines. EPO.
[3] U.S. Patent and Trademark Office. (2023). General patent info. USPTO.
[4] Cuba Patent Office. (2022). Patent procedures and filings. Oficina Cubana de Patentes.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.